A Validation Study for the Use of ROS1 Immunohistochemical Staining in Screening for ROS1 Translocations in Lung Cancer.

导出原文传递

翻译打印收藏纠错

第一作者： Patrizia,Viola

第一单位： Department of Histopathology, Royal Brompton and Harefield National Health Service Foundation Trust, London, United Kingdom.

作者： Patrizia,Viola ^[1] ; Manisha,Maurya ^[2] ; James,Croud ^[1] ; Jana,Gazdova ^[2] ; Nadia,Suleman ^[1] ; Eric,Lim ^[3] ; Tom,Newsom-Davis ^[4] ; Nick,Plowman ^[5] ; Alexandra,Rice ^[6] ; M Angeles,Montero ^[6] ; David,Gonzalez de Castro ^[2] ; Sanjay,Popat ^[7] ; Andrew G,Nicholson ^[8]

作者单位： Department of Histopathology, Royal Brompton and Harefield National Health Service Foundation Trust, London, United Kingdom. ^[1] Centre for Molecular Pathology, Royal Marsden Hospital, Sutton, United Kingdom. ^[2] Department of Thoracic Surgery, Royal Brompton and Harefield National Health Service Foundation Trust, London, United Kingdom; National Heart and Lung Institute, Imperial College, London, United Kingdom. ^[3] Department of Oncology, Chelsea and Westminster Hospital, London, United Kingdom. ^[4] Department of Oncology, St Bartholomew's Hospital, London, United Kingdom. ^[5] Department of Histopathology, Royal Brompton and Harefield National Health Service Foundation Trust, London, United Kingdom; National Heart and Lung Institute, Imperial College, London, United Kingdom. ^[6] Department of Medicine, Royal Marsden Hospital, London, United Kingdom. ^[7] Department of Histopathology, Royal Brompton and Harefield National Health Service Foundation Trust, London, United Kingdom; National Heart and Lung Institute, Imperial College, London, United Kingdom. Electronic address: a.nicholson@rbht.nhs.uk. ^[8]

关键词 FISH Immunohistochemistry Lung cancer ROS1 gene rearrangement